Constellation Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CNST and buy or sell other stocks, ETFs, and their options commission-free!About CNST
Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity.
CEOJigar Raythatha, MBA
CEOJigar Raythatha, MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2008
Founded2008
Employees—
Employees—
CNST Key Statistics
Market cap1.63B
Market cap1.63B
Price-Earnings ratio-11.21
Price-Earnings ratio-11.21
Dividend yield—
Dividend yield—
Average volume657.81K
Average volume657.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$39.30
52 Week high$39.30
52 Week low$17.00
52 Week low$17.00
Stock Snapshot
As of today, Constellation Pharmaceuticals(CNST) shares are valued at $33.99. The company's market cap stands at 1.63B, with a P/E ratio of -11.21.
On 2025-12-17, Constellation Pharmaceuticals(CNST) stock opened at —, reached a high of —, and a low of —.
The Constellation Pharmaceuticals(CNST)'s current trading volume is 0, compared to an average daily volume of 657.81K.
In the last year, Constellation Pharmaceuticals(CNST) shares hit a 52-week high of $39.30 and a 52-week low of $17.00.
In the last year, Constellation Pharmaceuticals(CNST) shares hit a 52-week high of $39.30 and a 52-week low of $17.00.
People also own
Based on the portfolios of people who own CNST. This list is generated using Robinhood data, and it’s not a recommendation.